TrialJournal of inherited metabolic disease2021

Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study.

Jerry Vockley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.